Skip to content

Impact of Arterial Cannulation Site on Vasopressor Requirement in Cardiac Surgery

Impact of Arterial Cannulation Site on Vasopressor Requirement During Cardiac Surgery: a Monocentric Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04620694
Acronym
ATRAP-GCS
Enrollment
350
Registered
2020-11-09
Start date
2020-10-01
Completion date
2021-02-28
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease

Keywords

Cardiac surgery, Aortic to radial arterial pressure gradient, Vasopressor

Brief summary

Choice of arterial cannulation site during cardiac surgery is controversial. Some physicians in our institution prefer radial artery site, others prefer aortic site (via femoral artery or brachial artery). The investigators aim to compare these two strategies for vasopressor requirement. The study hypothesis is that radial artery cannulation is associated with a larger dose of vasopressor due aortic to radial arterial pressure gradient phenomenon.

Interventions

DEVICEChoice of arterial cannulation site at the beginning of the surgery

Choice of arterial cannulation site at the beginning of the surgery is at the discretion of the anesthesia physician.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient * Scheduled for cardiac surgery with cardiopulmonary bypass

Exclusion criteria

* More than one arterial cannula at the beginning of the surgery

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative vasopressor requirementend of surgeryMean intraoperative dosage of Norepinephrine (µg.kg-1.min-1)

Countries

France

Contacts

Primary ContactRemi Schweizer, MD
remi.schweizer@chu-lyon.fr0033472318933
Backup ContactJean Luc FELLAHI, MD
jean-luc.fellahi@chu-lyon.fr0033472318933

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026